Efficacy and Safety of LP-005 Injection in Patients With Complement-Mediated Kidney Disease
NCT07363265
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
46
Enrollment
INDUSTRY
Sponsor class
Conditions
Complement-mediated Renal Diseases
Interventions
BIOLOGICAL:
LP-005 Injection
Sponsor
Longbio Pharma